Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: J Drug Deliv Sci Technol. 2018 Jul 17;47:159–166. doi: 10.1016/j.jddst.2018.07.010

Table 2:

NLC formulation composition.

Ingredients Amount (% w/v)
Lipid Phase
Compritol™ ATO 888 3
Olive oil 0.5–2
Gelucire™ 50/13 1.5
Curcumin 0.3
Aqueous phase
Vitamin E TPGS 0.4–1.0
Poloxamer 188 0.3–0.5
Glycerin 2.5
Water QS